These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36210027)

  • 121. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
    Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
    Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
    Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
    Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.
    Prabahran A; Koldej R; Chee L; Ritchie D
    Blood Adv; 2022 Mar; 6(6):1947-1959. PubMed ID: 34492685
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
    Kharfan-Dabaja MA; Kumar A; Ayala E; Aljurf M; Nishihori T; Marsh R; Burroughs LM; Majhail N; Al-Homsi AS; Al-Kadhimi ZS; Bar M; Bertaina A; Boelens JJ; Champlin R; Chaudhury S; DeFilipp Z; Dholaria B; El-Jawahri A; Fanning S; Fraint E; Gergis U; Giralt S; Hamilton BK; Hashmi SK; Horn B; Inamoto Y; Jacobsohn DA; Jain T; Johnston L; Kanate AS; Kansagra A; Kassim A; Kean LS; Kitko CL; Knight-Perry J; Kurtzberg J; Liu H; MacMillan ML; Mahmoudjafari Z; Mielcarek M; Mohty M; Nagler A; Nemecek E; Olson TS; Oran B; Perales MA; Prockop SE; Pulsipher MA; Pusic I; Riches ML; Rodriguez C; Romee R; Rondon G; Saad A; Shah N; Shaw PJ; Shenoy S; Sierra J; Talano J; Verneris MR; Veys P; Wagner JE; Savani BN; Hamadani M; Carpenter PA
    Transplant Cell Ther; 2021 Aug; 27(8):642-649. PubMed ID: 34304802
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation.
    Prabahran A; Koldej R; Chee L; Wong E; Ritchie D
    Leuk Lymphoma; 2021 Jun; 62(6):1482-1489. PubMed ID: 33522344
    [TBL] [Abstract][Full Text] [Related]  

  • 127. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.
    Berger M; Faraci M; Saglio F; Giardino S; Ernestina Vassallo E; Prete A; Fagioli F
    Pediatr Transplant; 2021 Aug; 25(5):e13909. PubMed ID: 33141997
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
    Cuadrado MM; Szydlo RM; Watts M; Patel N; Renshaw H; Dorman J; Lowdell M; Ings S; Anthias C; Madrigal A; Mackinnon S; Kottaridis P; Carpenter B; Hough R; Morris E; Thomson K; Peggs KS; Chakraverty R
    Haematologica; 2020 Nov; 105(11):2639-2646. PubMed ID: 33131253
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.
    Chen J; Wang H; Zhou J; Feng S
    Ther Adv Hematol; 2020; 11():2040620720948743. PubMed ID: 32874483
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplant.
    Tang FF; Sun YQ; Mo XD; Lv M; Chen YH; Wang Y; Xu LP; Zhang XH; Huang XJ
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1452-1458. PubMed ID: 32311479
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
    Kong Y
    Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhao Y; Gao F; Shi J; Luo Y; Tan Y; Lai X; Yu J; Huang H
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1898-1907. PubMed ID: 31176790
    [TBL] [Abstract][Full Text] [Related]  

  • 133. CD34
    Mohty R; Brissot E; Battipaglia G; Ruggeri A; Sestili S; Mediavilla C; Belhocine R; Dulery R; Mohty M; Malard F
    Curr Res Transl Med; 2019 Aug; 67(3):112-114. PubMed ID: 30591374
    [No Abstract]   [Full Text] [Related]  

  • 134. CD34
    Mainardi C; Ebinger M; Enkel S; Feuchtinger T; Teltschik HM; Eyrich M; Schumm M; Rabsteyn A; Schlegel P; Seitz C; Schwarze CP; Müller I; Greil J; Bader P; Schlegel PG; Martin D; Holzer U; Döring M; Handgretinger R; Lang P
    Br J Haematol; 2018 Jan; 180(1):90-99. PubMed ID: 29205259
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Fresh or Cryopreserved CD34
    Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
    Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
    [TBL] [Abstract][Full Text] [Related]  

  • 137. CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation.
    Stasia A; Ghiso A; Galaverna F; Raiola AM; Gualandi F; Luchetti S; Pozzi S; Varaldo R; Lamparelli T; Bregante S; Van Lint MT; di Grazia C; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1440-3. PubMed ID: 24862637
    [TBL] [Abstract][Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.